Hsa_circ_0050900 affects ferroptosis in intrahepatic cholangiocarcinoma cells by targeting hsa‑miR-605‑3p to regulate SLC3A2-Reference-Cited by-同舟云学术

Hsa_circ_0050900 affects ferroptosis in intrahepatic cholangiocarcinoma cells by targeting hsa‑miR-605‑3p to regulate SLC3A2

Published:2023-11-06 Issue:1 Volume:27 Page:
ISSN:1792-1074
Container-title:Oncology Letters
language:
Short-container-title:Oncol Lett

Author:

Shi Xiangtian¹,Yang Jiarui²,Wang Meng¹,Xia Long³,Zhang Lei⁴,Qiao Shan¹

Affiliation:

1. Department of Hepatobiliary Surgery, Bayannur Hospital, Bayannur, Inner Mongolia Autonomous Region 015000, P.R. China

2. Department of Hepatobiliary, Pancreatic and Splenic Surgery, Affiliated Dongguan Hospital, Southern Medical University (Dongguan People's Hospital), Dongguan, Guangdong 523058, P.R. China

3. Department of Hepatobiliary‑Pancreatic‑Splenic Surgery, Inner Mongolia Autonomous Region People's Hospital, Hohhot, Inner Mongolia Autonomous Region 010017, P.R. China

4. Department of Pancreatic Hepato‑Biliary‑Surgery, The Sixth Affiliated Hospital, Sun Yat‑sen University, Guangzhou, Guangdong 510655, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology

Reference44 articles.

1. Systemic therapies for intrahepatic cholangiocarcinoma;Kelley;J Hepatol,2020

2. Intrahepatic cholangiocarcinoma: Molecular markers for diagnosis and prognosis;Rahnemai-Azar;Surg Oncol,2017

3. Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians;Moris;CA Cancer J Clin,2023

4. Placental growth factor promotes tumour desmoplasia and treatment resistance in intrahepatic cholangiocarcinoma;Aoki;Gut,2022

5. Surgical management of intrahepatic cholangiocarcinoma;Hewitt;Expert Rev Anticancer Ther,2022